The authors reply

New England Journal of Medicine

Volumn 371, Issue 26, 2014, Pages 2534-

  Mayosi, Bongani M ^a   Ntsekhe, Mpiko ^a   Smieja, Marek ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; ISONIAZID; KANAMYCIN; OFLOXACIN; PLACEBO; PREDNISOLONE; RIFAMPICIN; STREPTOMYCIN;

CANCER ADJUVANT THERAPY; DRUG RESISTANT TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; LETTER; LUNG CANCER; MILIARY TUBERCULOSIS; MYCOBACTERIUM INDICUS PRANII; NONHUMAN; PERICARDIAL EFFUSION; TUBERCULOUS PERICARDITIS;

EID: 84920017733     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1413185     Document Type: Letter

References (5)

1. Rakshit S, Ponnusamy M, Papanna S, Saha B, Ahmed A, Nandi D. Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: critical roles of IFNgamma. Int J Cancer 2012; 130: 865-75.
2. Sur PK, Dastidar AG. Role of Mycobacterium w as adjuvant treatment of lung cancer (non-small cell lung cancer). J Indian Med Assoc 2003; 101: 118-20.
3. Magula NP, Madala ND, Kriel Y, et al. Prevalence of drug resistant tuberculosis in patients presenting with a large pericardial effusion at King Edward VIII Hospital. Int J Infect Dis 2014; 21: Suppl 1: 87.
4. Reuter H, Burgess LJ, Louw VJ, Doubell AF. Experience with adjunctive corticosteroids in managing tuberculous pericarditis. Cardiovasc J S Afr 2006; 17: 233-8.
5. Syed FF, Mayosi BM. A modern approach to tuberculosis pericarditis. Prog Cardiovasc Dis 2007; 50: 218-36.